Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rocket Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rocket Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Rocket Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is RCKT. The reporting company's CIK number is 1281895.
The total value of stock buying since 2005 is $26,734,874.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $42,799.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-04-02||Southwell David P (Director)||Option Ex||21,875||.00||0|
|2017-09-14||Ritter Dale (Vice President, Finance)||Option Ex||12,500||.00||0|
|2017-01-06||Southwell David P (President and CEO)||Buy||60,000||1.75||105,000|
|2016-05-13||Carroll J Martin (Director)||Buy||10,000||9.03||90,290|
|2015-07-14||Kantesaria Devang (10% Owner)||Option Ex||9,857||4.34||42,799|
|2015-02-23||Pitango G.c. Capital Holdings Ltd. (10% Owner)||Buy||212,375||6.00||1,274,250|
|2015-02-23||Kantesaria Devang (10% Owner)||Buy||814,166||6.00||4,884,996|
|2015-02-23||Devon Park Associates, Llc (10% Owner)||Buy||814,166||6.00||4,884,996|
|2015-02-23||Care Capital Offshore Investments Iii Lp (10% Owner)||Buy||603,832||6.00||3,622,992|
|2015-02-23||Medimmune Ventures, Inc. (10% Owner)||Buy||416,667||6.00||2,500,002|
|2015-02-23||Karabelas Argeris N (Director)||Buy||603,832||6.00||3,622,992|
|2015-02-23||Leschly Mark (10% Owner)||Buy||958,226||6.00||5,749,356|
Insider trading activities including stock purchases, stock sales, and option exercises of RCKT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rocket Pharmaceuticals, Inc. (symbol RCKT, CIK number 1281895) see the Securities and Exchange Commission (SEC) website.